openPR Logo
Press release

Bronchiolitis Drugs Market expected to reach USD 83.37 million by 2029

08-24-2022 01:23 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Bronchiolitis Drugs Market expected to reach USD 83.37 million

Bronchiolitis is a recurring lung illness that affects new-borns and small children. It causes inflammation and obstruction in the lungs' tiny airways (bronchioles). It can make you wheeze, cough and have trouble breathing. It occurs when the bronchioles, or small breathing tubes in the lungs, get inflamed. As a result of the mucus clogging the tubes, there isn't enough room for air to get in and out of the lungs. The respiratory syncytial virus (RSV), influenza (flu) viruses and rhinovirus are the most common causes of bronchiolitis.

Data Bridge Market Research analyses that the bronchiolitis drugs market was valued at USD 58.62 million in 2021 and is expected to reach USD 83.37 million by 2029, registering a CAGR of 4.50% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample PDF of the report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bronchiolitis-drugs-market

Bronchiolitis Drugs Market Dynamics

Drivers
Rise in the prevalence of respiratory syncytial virus (RSV) infection
The surging prevalence of respiratory syncytial virus (RSV) infection is a major factor driving the bronchiolitis drugs market's growth rate. According to the Centers for Disease Control and Prevention (CDC), respiratory syncytial virus (RSV) causes the hospitalization of approximately 1,32,000-172,000 children under the age of five and the death of approximately 14,000 adults over the age of 65 in the United States alone each year. Developing countries account for nearly all RSV-related mortality in children under the age of five. Because respiratory syncytial virus (RSV) infections have clinical signs that are similar to those of other respiratory diseases, there is a rising demand for rapid, specific, and sensitive diagnostic procedures.

High prevalence rate of smoking
The rise in prevalence rate of smoking will act as a major driver that will result in the expansion of the growth rate of the market. Smoking is one of the causative factor which increases the risk of viral bronchiolitis by raising breathing problems and hence will further cushion the growth rate of bronchiolitis drugs market.

Furthermore, rising initiatives by public and private organizations to spread awareness and rising healthcare expenditure will expand the bronchiolitis drugs market. Additionally, changing lifestyle of people and increasing number of cases of heart diseases and chronic lung disorders will result in the expansion of bronchiolitis drugs market. Along with this, rising incidences of respiratory diseases and increasing number of geriatric population will enhance the growth rate of the market.

Opportunities
Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the bronchiolitis drugs market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the bronchiolitis drugs market growth during the forecast period.

Some of the major players operating in the bronchiolitis drugs market are:
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Boehringer Ingelheim International GmbH. (Germany)
AstraZeneca (UK)
Johnson & Johnson Private Limited (US)
Merck & Co., Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Bristol-Myers Squibb Company (US)
Eli Lilly and Company (US)
Allergan (Ireland)
Abbott (US)
LEO Pharma A/S (Denmark)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Lupin (India)
Hikma Pharmaceuticals PLC (UK)
Amneal Pharmaceuticals LLC. (US)
Zydus Cadila (India)
Akorn, Incorporated (US)

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@- https://www.databridgemarketresearch.com/reports/global-bronchiolitis-drugs-market

Global Bronchiolitis Drugs Market Scope
The bronchiolitis drugs market is segmented on the basis of type, treatment, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment
Medication
Antiviral drugs
Aerosolized ribavirin
Bronchodilators
Corticosteroids
Oxygen Therapy
Intravenous Fluids
Others

Type
Viral Bronchiolitis
Bronchiolitis Obliterans
Others

Dosage Form
Injection
Tablets
Others

Route of Administration
Inhalational
Parenteral
Oral
Others

End-Users
Hospitals
Specialty Clinics
Homecare
Others

Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Bronchiolitis Drugs Market Regional Analysis/Insights
The bronchiolitis drugs market is analysed and market size insights and trends are provided by country, type, treatment, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the bronchiolitis drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the bronchiolitis drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022-2029 due to surging prevalence of inflammatory respiratory diseases in this region. Also, development of healthcare infrastructure will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Browse the complete table of contents at- https://www.databridgemarketresearch.com/toc/?dbmr=global-bronchiolitis-drugs-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiolitis Drugs Market expected to reach USD 83.37 million by 2029 here

News-ID: 2714770 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Bronchiolitis

Bronchiolitis Obliterans Syndrome Therapeutics 2025 | Immunosuppressives, Monocl …
The Bronchiolitis Obliterans Syndrome (BOS) Treatment Market is experiencing notable growth, propelled primarily by the increasing number of lung transplants worldwide, rising incidence of chronic respiratory illnesses, and greater awareness within the medical community. Treatment strategies for BOS traditionally emphasize immunosuppressive regimens such as calcineurin inhibitors, bronchodilators, inhaled corticosteroids, and procedures like plasmapheresis. Industry leaders such as Zambon Pharma, Incyte Corporation, Genentech, GlaxoSmithKline, and Altavant Sciences are at the forefront
Advancements In At-Home Nebulized Therapies Accelerate Treatment For Bronchiolit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Bronchiolitis Obliterans Syndrome Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, there has been significant growth in the bronchiolitis obliterans syndrome market. It is projected to expand from $1.46 billion in 2024 to $1.59 billion in 2025, with a compound annual growth
Rising Demand for Advanced Treatments to Propel Obliterative Bronchiolitis Marke …
The Obliterative Bronchiolitis Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Obliterative Bronchiolitis market forward, including increasing market share, dynamic segmentation,
Bronchiolitis Market Projected to Show Strong Growth| Pfizer, Intas Pharmaceutic …
Advance Market Analytics published a new research publication on "Bronchiolitis Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Bronchiolitis market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of This Research
Bronchiolitis Obliterans Syndrome Market - Advancing Lung Health: BOS Solutions …
Newark, New Castle, USA - new report, titled Bronchiolitis Obliterans Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Bronchiolitis Obliterans Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Bronchiolitis Obliterans Syndrome market. The report offers an overview of
Precise Analysis on Global Bronchiolitis Obliterans Clinical Trials Reviewed for …
The global market for Bronchiolitis Obliterans is likely to attain novel growth heights with fast transitioning end-user preferences. Burgeoning vegan population across regions is attributed to manifest favorably towards to the growth of report title as “Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2018” in foreseeable future. The fast expanding online repository of Market Research Hub (MRH) assesses recent market advances and their reciprocal implications on holistic growth of Bronchiolitis